Camden Capital, LLC Harvard Bioscience Inc Transaction History
Camden Capital, LLC
- $887 Million
- Q4 2024
A detailed history of Camden Capital, LLC transactions in Harvard Bioscience Inc stock. As of the latest transaction made, Camden Capital, LLC holds 14,712 shares of HBIO stock, worth $19,566. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14,712
Previous 14,712
-0.0%
Holding current value
$19,566
Previous $39,000
20.51%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding HBIO
# of Institutions
98Shares Held
31.2MCall Options Held
700Put Options Held
2.1K-
Black Rock Inc. New York, NY2.84MShares$3.78 Million0.0% of portfolio
-
Punch & Associates Investment Management, Inc. Edina, MN2.76MShares$3.66 Million0.35% of portfolio
-
Harvey Partners, LLC Tarrytown, NY2.68MShares$3.57 Million0.66% of portfolio
-
Amh Equity LTD2.5MShares$3.33 Million5.77% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.16MShares$2.87 Million0.0% of portfolio
About HARVARD BIOSCIENCE INC
- Ticker HBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 41,636,500
- Market Cap $55.4M
- Description
- Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...